v3.22.2.2
Document and Entity Information - shares
 9 Months Ended
Aug. 31, 2022
Sep. 30, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Aug. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --11-30  
Entity Registrant Name NURIX THERAPEUTICS, INC.  
Entity Central Index Key 0001549595  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Shell Company false  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity File Number 001-39398  
Entity Tax Identification Number 27-0838048  
Entity Address, Address Line One 1700 Owens Street  
Entity Address, Address Line Two Suite 205  
Entity Address, City or Town San Francisco  
Entity Address, State or Province CA  
Entity Interactive Data Current Yes  
Entity Address, Postal Zip Code 94158  
City Area Code 415  
Local Phone Number 660-5320  
Entity Incorporation, State or Country Code DE  
Entity Common Stock, Shares Outstanding   47,147,781
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NRIX  
Security Exchange Name NASDAQ